2.9899
+0.0099
+(0.33%)
At close: January 30 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-17,236.0000
-34,317.0000
-32,386.0000
-21,596.0000
Investing Cash Flow
--
3,804.0000
16,575.0000
36,900.0000
-40,768.0000
Financing Cash Flow
--
9,976.0000
16,428.0000
1,034.0000
62,774.0000
End Cash Position
--
5,686.0000
9,142.0000
10,456.0000
4,908.0000
Income Tax Paid Supplemental Data
--
18.0000
8.0000
--
--
Interest Paid Supplemental Data
--
1,038.0000
734.0000
--
--
Capital Expenditure
--
-196.0000
-1,767.0000
-2,993.0000
-1,176.0000
Issuance of Capital Stock
--
8,723.0000
4,423.0000
--
62,757.0000
Issuance of Debt
--
--
11,711.0000
--
--
Repayment of Debt
--
-2,618.0000
-402.0000
--
--
Free Cash Flow
--
-17,432.0000
-36,084.0000
-35,379.0000
-22,772.0000
12/31/2020 - 6/26/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COYA Coya Therapeutics, Inc.
5.86
+0.17%
ORGS Orgenesis Inc.
1.4400
+2.86%
ELDN Eledon Pharmaceuticals, Inc.
4.7800
+0.84%
NRXS NeurAxis, Inc.
2.7100
+0.34%
IMMX Immix Biopharma, Inc.
1.9700
-4.37%
GYRE Gyre Therapeutics, Inc.
11.50
+0.17%
URGN UroGen Pharma Ltd.
11.35
+3.09%
PPTDF PeptiDream Inc.
17.85
0.00%
LRMR Larimar Therapeutics, Inc.
3.9700
+7.01%
LXEO Lexeo Therapeutics, Inc.
5.25
+0.77%